Monique Evangeline Hinchcliff

About

Dr. Monique Evangeline Hinchcliff is an Associate Professor of Medicine specializing in Rheumatology, Allergy & Immunology at Yale School of Medicine. She serves as the Director of the Yale Scleroderma Program and the Director of Clinical and Translational Research in the Internal Medicine Rheumatology section. Additionally, she is the Associate Director of the Clinical and Translational Research Accelerator at Yale. Dr. Hinchcliff earned her medical degree from Rosalind Franklin University Chicago Medical School and completed her residency in medicine at Norwalk Hospital in Connecticut. She pursued rheumatology fellowship training at Northwestern University Feinberg School of Medicine in Chicago, where she also obtained a Master of Science degree in Clinical Investigation. Her research program focuses on clinical, interventional, and observational studies aimed at better understanding systemic sclerosis and identifying new and repurposed treatments for patients with this condition. Dr. Hinchcliff maintains active research collaborations both within the United States and internationally. Clinically, she leads a multidisciplinary team of specialists dedicated to the care of patients with systemic sclerosis. She is actively involved in ongoing clinical trials to provide patients access to the latest potentially beneficial treatments.

Research topics

• Medicine
• Internal medicine
• Physical therapy
• Pathology
• Intensive care medicine
• Psychiatry
• Immunology
• Clinical psychology
• Emergency medicine
• Psychotherapist

Selected publications

• Electronic health record alerts for acute kidney injury: multicenter, randomized clinical trial

  BMJ · 2021 · 188 citations

  OBJECTIVE: To determine whether electronic health record alerts for acute kidney injury would improve patient outcomes of mortality, dialysis, and progression of acute kidney injury. DESIGN: Double blinded, multicenter, parallel, randomized controlled trial. SETTING: Six hospitals (four teaching and two non-teaching) in the Yale New Haven Health System in Connecticut and Rhode Island, US, ranging from small community hospitals to large tertiary care centers. PARTICIPANTS: 6030 adult inpatients w…

  DOI

• 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases

  Arthritis & Rheumatology · 2024 · 156 citations

  OBJECTIVE: We provide evidence-based recommendations regarding the treatment of interstitial lung disease (ILD) in adults with systemic autoimmune rheumatic diseases (SARDs). METHODS: We developed clinically relevant population, intervention, comparator, and outcomes questions. A systematic literature review was then performed, and the available evidence was rated using the Grading of Recommendations, Assessment, Development, and Evaluation methodology. A panel of clinicians and patients reached…

  PublisherOA PDFDOI

• 2023 American College of Rheumatology (<scp>ACR</scp>)/American College of Chest Physicians (<scp>CHEST</scp>) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases

  Arthritis & Rheumatology · 2024 · 118 citations

  OBJECTIVE: We provide evidence-based recommendations regarding screening for interstitial lung disease (ILD) and the monitoring for ILD progression in people with systemic autoimmune rheumatic diseases (SARDs), specifically rheumatoid arthritis, systemic sclerosis, idiopathic inflammatory myopathies, mixed connective tissue disease, and Sjögren disease. METHODS: We developed clinically relevant population, intervention, comparator, and outcomes questions related to screening and monitoring for I…

  PublisherOA PDFDOI

• The Association of COVID-19 With Acute Kidney Injury Independent of Severity of Illness: A Multicenter Cohort Study

  American Journal of Kidney Diseases · 2021 · 99 citations

  DOI

• Changes in mental health symptoms from pre-COVID-19 to COVID-19 among participants with systemic sclerosis from four countries: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study

  Journal of Psychosomatic Research · 2020 · 44 citations

  PublisherOA PDFDOI

Recent grants

• NIH Grant R21AR068035

  NIH · $400k · 2018

• Pathogenic Wnt-beta catenin target genes in macrophages and fibrosis

  NIH · $2.6M · 2019–2025

• NIH Grant K23AR059763

  NIH · $390k · 2016

Frequent coauthors

• John Varga

  231 shared

• Virginia Steen

  Georgetown University Medical Center

  212 shared

• Maureen D. Mayes

  The University of Texas Health Science Center at Houston

  205 shared

• Robyn T. Domsic

  University of Pittsburgh

  202 shared

• Leland W.K. Chung

  Stanford University

  201 shared

• Laura K. Hummers

  Johns Hopkins University

  186 shared

• Vivien Hsu

  Sir Charles Gairdner Hospital

  186 shared

• Daniel E. Fürst

  University of Florence

  178 shared

Education

• M.D., Medicine

  Yale School of Medicine

  2000

• M.S., Immunology

  University of California, San Francisco

  1995

• B.S., Biology

  University of California, San Francisco

  1991

Similar researchers at Yale University

• Richard Bucalah-114
• Lisa Gale Suterh-44
• Linda Bockenstedth-39